Ligand Pharmaceuticals LGND Debt Issuance Costs
Debt Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's debt issuance costs?
- Ligand Pharmaceuticals (LGND) reported debt issuance costs of $50K in Q1 2026.
- How has Ligand Pharmaceuticals's debt issuance costs changed year-over-year?
- Ligand Pharmaceuticals's debt issuance costs decreased by 29.6% year-over-year, from $71K to $50K.
- What does debt issuance costs mean?
- Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.